Delta sleep-inducing peptide (DSIP) is a naturally-occurring neuropeptide studied through laboratory research on sleep physiology, neuroendocrine signaling, circadian biology, and central nervous system function
This approach is based on the principle that targeted practice is often more effective than general repetition
Novo Nordisk missed a mandatory patent maintenance fee, causing its foundational Canadian patent to lapse in 2020
Delayed gastric emptying induced by GLP-1 receptor agonists carries important clinical implications that extend beyond the intended therapeutic effects
However, translation to human wellness optimization protocols has not been established
Dihexa is a modified hexanoic acid-Tyr-Ile dipeptide derived from angiotensin IV, developed at Washington State University as an ultra-potent cognitive enhancer